UNILABS LABORATORIEMEDISIN AS

0380 OSLO

Finances

Share Ownership

Return on Equity

9,5 %

Current Ratio

1,09

Debt-to-Equity Ratio

1,01

Key figures (NOK)	2022	2021	2020	2019
Revenue	153 503 000	173 549 000	163 037 000	156 852 000
Net Income	3 408 000	7 153 000	17 816 000	24 938 000
Total Assets	113 991 000	135 947 000	98 454 000	96 718 000
Total Equity	35 861 000	32 453 000	25 300 000	7 485 000

Income (NOK)	2022	2021	2020	2019
Revenue	153 503 000	173 549 000	163 037 000	156 852 000
Expenditure	146 574 000	162 832 000	138 596 000	123 276 000
Operating Profit	6 929 000	10 716 000	24 441 000	33 575 000
Financial Income	238 000	27 000	108 000	220 000
Financial Costs	2 962 000	1 674 000	1 838 000	2 008 000
Financial Balance	−2 724 000	−1 647 000	−1 730 000	−1 788 000
Earnings Before Tax	4 205 000	9 068 000	22 711 000	31 788 000
Tax	798 000	1 916 000	4 895 000	6 850 000
Net Income	3 408 000	7 153 000	17 816 000	24 938 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	68 434 000	75 084 000	45 457 000	40 114 000
Total Current Assets	45 557 000	60 863 000	52 996 000	56 603 000
Total Assets	113 991 000	135 947 000	98 454 000	96 718 000
Total Retained Equity	24 116 000	20 708 000	13 555 000	−4 260 000
Total Equity	35 861 000	32 453 000	25 300 000	7 485 000
Total Long-Term Debt	36 234 000	55 999 000	17 762 000	23 059 000
Total Current Debt	41 897 000	47 496 000	55 391 000	66 174 000
Total Equity and Debt	113 991 000	135 947 000	98 454 000	96 718 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	152 979 000	173 442 000	162 927 000	156 831 000
Other Income	523 000	107 000	110 000	22 000
Revenue	153 503 000	173 549 000	163 037 000	156 852 000
Cost of Goods Sold	37 756 000	60 386 000	40 967 000	33 187 000
Salary Costs	61 956 000	56 978 000	54 035 000	52 204 000
Depreciation	12 223 000	14 478 000	14 420 000	12 423 000
Impairment	0	0	0	0
Expenditure	146 574 000	162 832 000	138 596 000	123 276 000
Operating Profit	6 929 000	10 716 000	24 441 000	33 575 000
Financial Income	238 000	27 000	108 000	220 000
Financial Costs	2 962 000	1 674 000	1 838 000	2 008 000
Financial Balance	−2 724 000	−1 647 000	−1 730 000	−1 788 000
Dividends	0	0	0	0
Net Income	3 408 000	7 153 000	17 816 000	24 938 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	1 004 000	1 564 000	1 486 000	1 524 000
Real Eastate	38 336 000	55 934 000	22 503 000	29 246 000
Machinery and Plant Facilities	23 105 000	10 036 000	19 040 000	8 974 000
Fixtures	5 525 000	7 258 000	2 234 000	321 000
Total Tangible Assets	66 966 000	73 228 000	43 778 000	38 541 000
Total Fiancial Fixed Assets	464 000	292 000	194 000	49 000
Total Fixed Assets	68 434 000	75 084 000	45 457 000	40 114 000
Stock	3 910 000	10 452 000	9 493 000	5 534 000
Total Investments	0	0	0	0
Cash, Bank	26 612 000	35 124 000	29 678 000	40 294 000
Total Current Assets	45 557 000	60 863 000	52 996 000	56 603 000
Total Assets	113 991 000	135 947 000	98 454 000	96 718 000
Total Equity	35 861 000	32 453 000	25 300 000	7 485 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	36 234 000	55 999 000	17 762 000	23 059 000
Creditors	13 609 000	22 214 000	17 196 000	12 049 000
Unpaid Taxes	5 489 000	5 866 000	5 507 000	4 140 000
Dividends	0	0	0	0
Other Current Debt	16 673 000	10 264 000	21 669 000	10 583 000
Total Current Debt	41 897 000	47 496 000	55 391 000	66 174 000
Total Equity and Debt	113 991 000	135 947 000	98 454 000	96 718 000

Financial indicators	2022	2021	2020	2019
Return on Equity	9,5 %	22,04 %	70,42 %	333,17 %
Debt-to-Equity Ratio	1,01	1,73	0,7	3,08
Operating Profit Margin	4,51 %	6,17 %	14,99 %	21,41 %
Current Ratio	1,09	1,28	0,96	0,86
Quick Ratio	1,2	1,64	1,15	0,93
Equity Ratio	0,31	0,24	0,26	0,08
Gross Profit Margin	75,4 %	65,21 %	74,87 %	78,84 %